The study is a prospective, trial to test the safety and feasibility of injecting autologous, isolated, sterile centrifuged NBMC, and Ignite® DBM in the treatment of high risk non union/delayed fractures. Another objective is to turn this procedure to a standard care protocol in our department .
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Unnamed facility
Jerusalem, Israel
clinical and radiological bony union at 3 months and 6 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.